Analysis of biomarkers in a pilot study of pertuzumab, trastuzumab and eribulin for advanced HER2 positive breast cancer

Authors :: Toshiro Mizuno
Yoshihiro Miyahara
Yasutaka Tono
Naoyuki Katayama
Mikiya Ishihara
Taizo Shiraishi
Hiroaki Ikeda
Hiroshi Shiku
Source :: Annals of Oncology. 27:vii88
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Hematology
chemistry.chemical_compound
chemistry
Trastuzumab
HER2 Positive Breast Cancer
Internal medicine
medicine
Pertuzumab
business
medicine.drug
Eribulin

Full Text Access

Tools